SCI时时刷

search
Levetiracetam Interaction with Direct Oral Anticoagulants: A Pharmacovigilance Study
Levetiracetam Interaction with Direct Oral Anticoagulants: A Pharmacovigilance Study
Levetiracetam is widely used in post-stroke epilepsy. However, it is suspected to possess P-glycoprotein (P-gp) induction ...
Long-Term Treatment Over 52 Weeks with Monthly Fremanezumab in Drug-Resistant Migraine: A Prospective Multicenter Cohort Study
Long-Term Treatment Over 52 Weeks with Monthly Fremanezumab in Drug-Resistant Migraine: A Prospective Multicenter Cohort Study
Real-world studies on fremanezumab, an anti-calcitonin gene-related peptide monoclonal antibody for migraine prevention, a...
Context is a Critical for Psychoactive Drug Effects
Context is a Critical for Psychoactive Drug Effects
Pouyan N, Younesi Sisi F, Kargar A, Scheidegger M, McIntyre R, Morrow J. The effects of lysergic acid diethylamide (LSD) o...
The effects of Lysergic Acid Diethylamide (LSD) on the Positive Valence Systems: A Research Domain Criteria (RDoC)-Informed Systematic Review
The effects of Lysergic Acid Diethylamide (LSD) on the Positive Valence Systems: A Research Domain Criteria (RDoC)-Informed Systematic Review
The renewed interest in psychedelic research provides growing evidence of potentially unique effects on various aspects of...
Current Insights into Diagnosing and Treating Neurotuberculosis in Adults
Current Insights into Diagnosing and Treating Neurotuberculosis in Adults
Neurotuberculosis has the highest morbidity and mortality risk of all forms of extrapulmonary tuberculosis (TB). Early tre...
A Semi-Naturalistic, Open-Label Trial Examining the Effect of Prescribed Medical Cannabis on Neurocognitive Performance
A Semi-Naturalistic, Open-Label Trial Examining the Effect of Prescribed Medical Cannabis on Neurocognitive Performance
Medical cannabis use is increasing in Australia and other jurisdictions, yet little is known about the effects of medical ...
Solriamfetol: A Review in Excessive Daytime Sleepiness Associated with Narcolepsy and Obstructive Sleep Apnoea
Solriamfetol: A Review in Excessive Daytime Sleepiness Associated with Narcolepsy and Obstructive Sleep Apnoea
Solriamfetol (SUNOSI®) is an oral selective dopamine and norepinephrine reuptake inhibitor approved in the EU and the...
Dextromethorphan-Bupropion for the Treatment of Depression: A Systematic Review of Efficacy and Safety in Clinical Trials
Dextromethorphan-Bupropion for the Treatment of Depression: A Systematic Review of Efficacy and Safety in Clinical Trials
A significant proportion of adults with major depressive disorder (MDD) do not respond to treatments which are currently u...
Stopping Disease-Modifying Treatments in Multiple Sclerosis: A Systematic Review and Meta-Analysis of Real-World Studies
Stopping Disease-Modifying Treatments in Multiple Sclerosis: A Systematic Review and Meta-Analysis of Real-World Studies
The question of whether multiple sclerosis requires life-long disease-modifying treatments (DMTs) remains unanswered. Some...
Lysergic Acid Diethylamide (LSD) for the Treatment of Anxiety Disorders: Preclinical and Clinical Evidence
Lysergic Acid Diethylamide (LSD) for the Treatment of Anxiety Disorders: Preclinical and Clinical Evidence
Anxiety disorders (ADs) represent the sixth leading cause of disability worldwide, resulting in a significant global econo...
Over the Counter Supplements for Memory: A Review of Available Evidence
Over the Counter Supplements for Memory: A Review of Available Evidence
In 2021, the Global Brain Health Supplement Industry Market size was valued at US$7.6 billion. It is predicted to increase...
New GABA-Targeting Therapies for the Treatment of Seizures and Epilepsy: II. Treatments in Clinical Development
New GABA-Targeting Therapies for the Treatment of Seizures and Epilepsy: II. Treatments in Clinical Development
The inhibitory neurotransmitter γ-aminobutyric acid (GABA) plays an important role in the modulation of neuronal exci...
GABA-ergic Modulators: New Therapeutic Approaches to Premenstrual Dysphoric Disorder
GABA-ergic Modulators: New Therapeutic Approaches to Premenstrual Dysphoric Disorder
Premenstrual dysphoric disorder (PMDD) is characterized by the predictable onset of mood and physical symptoms secondary t...
The Utilization of Low Dose Naltrexone for Chronic Pain
The Utilization of Low Dose Naltrexone for Chronic Pain
Naltrexone is a mu-opioid receptor antagonist with a long half-life compared with naloxone. Both of these drugs, along wit...
Number, Duration, and Distribution of Wake Bouts in Patients with Insomnia Disorder: Effect of Daridorexant and Zolpidem
Number, Duration, and Distribution of Wake Bouts in Patients with Insomnia Disorder: Effect of Daridorexant and Zolpidem
Daridorexant, a dual orexin receptor antagonist approved in early 2022, reduces wake after sleep onset without reducing th...
Acute Valproate-Induced Encephalopathy in Status Epilepticus: A Registry-Based Assessment
Acute Valproate-Induced Encephalopathy in Status Epilepticus: A Registry-Based Assessment
Valproate-induced encephalopathy (VIE) affects between 0.1% and 2.5% of patients under long-term epilepsy treatment. Its f...
Amyloid-Lowering Monoclonal Antibodies for the Treatment of Early Alzheimer’s Disease
Amyloid-Lowering Monoclonal Antibodies for the Treatment of Early Alzheimer’s Disease
Alzheimer's disease (AD) is the leading cause of dementia worldwide. Numerous biomarker studies have clearly demonstra...
Increased Metabolic Potential, Efficacy, and Safety of Emerging Treatments in Schizophrenia
Increased Metabolic Potential, Efficacy, and Safety of Emerging Treatments in Schizophrenia
Patients with schizophrenia experience a broad range of detrimental health outcomes resulting from illness severity, heter...
Extended-Release Viloxazine Compared with Atomoxetine for Attention Deficit Hyperactivity Disorder
Extended-Release Viloxazine Compared with Atomoxetine for Attention Deficit Hyperactivity Disorder
In our outpatient pediatric and adult psychiatry centers, we reserve psychostimulants for predominantly inattentive attent...
Correction to: Rimegepant: A Review in the Acute Treatment and Preventive Treatment of Migraine
Correction to: Rimegepant: A Review in the Acute Treatment and Preventive Treatment of Migraine
Open Access This article is licensed under a Creative Commons Attribution-NonCommercial 4.0 International ...